ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselCanVirex AG
CanVirex AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

CanVirex AG develops cancer immunotherapies based on an attenuated measles-virus platform. Its lead clinical candidate, Mevacil, is designed for solid tumors and combines direct tumor-cell destruction with local immune activation through IL-12.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered3
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

CanVirex AG

Oncolytic Immunotherapy (Measles Vector Platform)
Oncolytic measles vectors for cancer immunotherapy, with selective tumor-cell lysis, immune-modulating transgenes and patient-specific immune activation against solid tumors.
Vector-based Vaccine Development
Measles vector platform for delivering pathogen-specific antigens for vaccination against infectious diseases, including SARS-CoV-2 antigens and cellular and humoral immune responses.
Biomarker and Translational Program
Supportive translational program with testing of molecular signatures and predictive biomarkers for patient-specific selection in future clinical trials.
Trust & reputation

ranQ Trust Score of CanVirex AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

CanVirex AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
CanVirex AG scores 82.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
CanVirex AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
CanVirex AG scores 22.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.22.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

CanVirex AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once CanVirex AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

CanVirex AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CanVirex AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CanVirex AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 9
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-228.978.735
Founded
2017 · 9 years
Last commercial register change
June 18, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RA
    Rocketvax AG
    Basel
    AS
    Azafaros Switzerland AG
    Basel
    TP
    Torpedo Pharmaceuticals AG
    Basel
    RA
    Rhenochem AG
    Basel
    LG
    Lonza Group AG
    Basel
    FA
    FimmCyte AG
    Basel
    NA
    NOUSCOM AG
    Basel
    FI
    FatiAbGen International GmbH
    Basel